104 related articles for article (PubMed ID: 15299606)
1. Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
Damas AM; Ribeiro S; Lamzin VS; Palha JA; Saraiva MJ
Acta Crystallogr D Biol Crystallogr; 1996 Sep; 52(Pt 5):966-72. PubMed ID: 15299606
[TBL] [Abstract][Full Text] [Related]
2. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.
Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC
J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699
[TBL] [Abstract][Full Text] [Related]
3. Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.
Redondo C; Damas AM; Olofsson A; Lundgren E; Saraiva MJ
J Mol Biol; 2000 Dec; 304(3):461-70. PubMed ID: 11090287
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant transthyretin.
Sebastião P; Dauter Z; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 1996 May; 52(Pt 3):566-8. PubMed ID: 15299680
[TBL] [Abstract][Full Text] [Related]
5. X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.
Neto-Silva RM; Macedo-Ribeiro S; Pereira PJ; Coll M; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2005 Mar; 61(Pt 3):333-9. PubMed ID: 15735344
[TBL] [Abstract][Full Text] [Related]
6. The pathway by which the tetrameric protein transthyretin dissociates.
Foss TR; Wiseman RL; Kelly JW
Biochemistry; 2005 Nov; 44(47):15525-33. PubMed ID: 16300401
[TBL] [Abstract][Full Text] [Related]
7. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
[TBL] [Abstract][Full Text] [Related]
8. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
[TBL] [Abstract][Full Text] [Related]
9. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M
Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296
[TBL] [Abstract][Full Text] [Related]
10. Different disease-causing mutations in transthyretin trigger the same conformational conversion.
Steward RE; Armen RS; Daggett V
Protein Eng Des Sel; 2008 Mar; 21(3):187-95. PubMed ID: 18276611
[TBL] [Abstract][Full Text] [Related]
11. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
12. Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
Shinohara Y; Mizuguchi M; Matsubara K; Takeuchi M; Matsuura A; Aoki T; Igarashi K; Nagadome H; Terada Y; Kawano K
Biochemistry; 2003 Dec; 42(51):15053-60. PubMed ID: 14690414
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structure.
Wojtczak A
Acta Biochim Pol; 1997; 44(3):505-17. PubMed ID: 9511961
[TBL] [Abstract][Full Text] [Related]
14. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
Liepnieks JJ; Benson MD
Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687
[TBL] [Abstract][Full Text] [Related]
15. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
[TBL] [Abstract][Full Text] [Related]
16. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.
Liepnieks JJ; Wilson DL; Benson MD
Amyloid; 2006 Sep; 13(3):170-7. PubMed ID: 17062384
[TBL] [Abstract][Full Text] [Related]
17. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
[TBL] [Abstract][Full Text] [Related]
18. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
Sekijima Y; Dendle MT; Wiseman RL; White JT; D'Haeze W; Kelly JW
Amyloid; 2006 Jun; 13(2):57-66. PubMed ID: 16911959
[TBL] [Abstract][Full Text] [Related]
19. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis.
Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P
J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.
Lei M; Yang M; Huo S
J Struct Biol; 2004 Nov; 148(2):153-68. PubMed ID: 15477096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
